Showing results (331-340 of 340) with videos related to
Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
Kidney International|October 1, 2020
International consensus definitions of clinical trial outcomes for kidney failure: 2020Adeera Levin, Rajiv Agarwal, William G Herrington, et al.The New England Journal of Medicine|April 17, 2019
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Meg J Jardine, Bruce Neal, et al.Circulation|July 12, 2019
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention GroupsKenneth W Mahaffey, Meg J Jardine, Severine Bompoint, et al.Kidney International|August 31, 2024
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slopeSatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.BMC Nephrology|July 1, 2020
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocolKim M Gooding, Chrysta Lienczewski, Massimo Papale, et al.Kidney International. Supplement|March 9, 2005
A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004Philip Kam-Tao Li, Jan J Weening, John Dirks, et al.Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.European Heart Journal|January 24, 2023
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium studyPatrick B Mark, Juan J Carrero, Kunihiro Matsushita, et al.Kidney International|February 4, 2011
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohortsBrad C Astor, Kunihiro Matsushita, Ron T Gansevoort, et al.Pageof 34